This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition ...

Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that ...

Boston Scientific has agreed to acquire Penumbra in a cash-and-stock deal worth $14.5 billion. The addition of Penumbra, ...

Boston Scientific (BSX) on Thursday announced a definitive agreement to acquire Penumbra (PEN) in a cash and stock ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Penumbra (PEN) climbs on strong Q4 results and acquisition agreement with Boston Scientific (BSX), deal valued at $14.5B.

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

On January 6, JPMorgan reiterated Boston Scientific Corporation (NYSE:BSX) is one of its top pick stocks in the healthcare ...

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5  billion deal on Thursday, its second‑largest takeover ever, ...